Driven by policies such as the "Implementation Plan for Digital and Intelligent Transformation of the Pharmaceutical Industry (2025-2030)" and the "Opinions on Comprehensively Deepening the Reform of Drug and Medical Device Regulation to Promote High-quality Development of the Pharmaceutical Industry", the pharmaceutical packaging industry is accelerating towards high-end, intelligent, and environmentally friendly development.

Among them, medicinal cold-stamped aluminum packaging materials have become the preferred packaging materials for highly sensitive drugs such as biologics and vaccines, thanks to their excellent sealing performance (oxygen transmission rate <0.5 cc/m²·day) and superior biocompatibility.

Industry trends and company actions:

Market Growth: By 2025, the global pharmaceutical packaging market is expected to surpass $58.7 billion. In China, the annual compound growth rate (CAGR) for medicinal aluminum foil is projected to reach 9%, with the demand for high-barrier cold-stamped aluminum experiencing an annual growth rate exceeding 15%.

As a leading enterprise in the industry, Jierui has deployed intelligent production lines (such as AI quality inspection systems, reducing labor costs by 60%) and launched a recyclable aluminum foil + bio-based coating solution, taking the lead in responding to the EU's 2030 plastic ban.

Technological breakthrough: Our self-developed ultra-thin aluminum foil (<20μm) and nano-corrosion-resistant coating have successfully achieved import substitution, helping a vaccine client reduce cold chain packaging costs by 40%. The product has also passed the EU CEP certification.

Policy Adaptation: The "Connected Evaluation and Approval System" of the National Medical Products Administration has included cold-stamped aluminum as a key packaging material for injections. Our products have passed international certifications such as GMP and ISO 15378, providing pharmaceutical companies with compliance support throughout the entire product lifecycle.

Customer value:

Precision barrier design: UV protective coating can be customized for photosensitive drugs, extending the shelf life by 20%;

Cost reduction and efficiency improvement: The automated production line supports high-speed stamping at a rate of 100,000 pieces per hour, reducing overall costs by 18%;

Green transformation support: The recyclable aluminum foil solution helps pharmaceutical companies reduce carbon emissions by 50%, accelerating the implementation of ESG strategies.